Sign in
Active, not recruitingNo phase

Neurofeedback in Treatment of Attention Deficit Hyperactivity Disorder

Key facts

Who runs it
Tanta University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
40 people, planned
Started
1 Oct 2025
Ended
Feb 2026
Type of study
Interventional
Treatments tested
  • Neurofeedback
Record updated
16 December 2025

Who can take part

Age
12 years to 18 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Participants are between 12- 18 years old
  • Both sexes are included (males \& females)
  • Willingness to participate to complete study procedures

Who cannot take part

  • Other Psychiatric disorders
  • Unwilling to participate in the study
  • Intellectual disability

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Attention-deficit/hyperactivity disorder (ADHD) is a common , chronic , and debilitating disorder . Although pharmacological treatments for ADHD can be easily implemented and are usually effective, their long-term therapeutic effects are still uncertain and adverse events are common, especially sleep problems, decreased appetite, and growth deceleration. Furthermore, psychosocial treatments, such eas parental training and behavioral therapy seem to be effective only during its delivery, and their effects are rarely sustained long-term .

Read full original descriptionShow less

Neurofeedback is a biofeedback method based on the rationale that there is a relationship between surface EEG and the underlying thalamocortical mechanisms responsible for its rhythms and frequency modulations .

Variations in alertness and behavioural control appear directly related to thalamocortical generator mechanisms. The principle of NF is that over time, participants learn operant control of their EEG and change from an "abnormal" state to one resembling that of typically developing children. This process is thought to eventually remediate the symptoms associated with ADHD .

The group in the trial

  • Effectiveness of Neurofeedback in treatment of Attention Deficit Hyperactivity DisorderTreatment being tested

    3- Neurofeedback: \- The patients will receive 30 sessions each lasting 50 minutes.

    Treatment: Neurofeedback

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effectiveness of Neurofeedback in Treatment of Attention Deficit Hyperactivity Disorder in a Sample of Patients in Tanta, Egypt
Record updated
16 December 2025